Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ENSG vs PACS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ENSG Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–3 Matrix Metrics)

ENSG Overall Winner 6-Pillar Tally: ENSG 4 – 2 PACS Matrix Metrics: ENSG 6 – 3 PACS

As of Nov 20, 2026, The Ensign Group, Inc. (ENSG) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ENSG carries a Unified Composite Score of 48.3/100 (HOLD) at $176.32 (20.1x Forward P/E, 8.8% operating margin), whereas PACS carries 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ENSG vs PACS
ENSG NASDAQ Head-to-Head Winner
The Ensign Group, Inc.
Services-Skilled Nursing Care Facilities
$176.32
-0.15% 1D
Market Cap $10.3B
TTM Revenue $5.67B
Forward P/E 20.1x
Beta / 30D Vol 0.12β · 42% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 67.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 44
RSI-14: 43.5 · SMA20: $182.49 · SMA50: $177.52
PACS NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap $6.8B
TTM Revenue $5.71B
Forward P/E 15.3x
Beta / 30D Vol 0.78β · 51% Vol
Unified Composite Score
46.8 / 100 HOLD
Tech 35.0 Fund 48.0 Flow 62.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.2 · SMA20: $48.01 · SMA50: $45.43

6-Pillar Scorecard Institutional Category Breakdown (ENSG 4 – 2 PACS)

Columns: Metric · ENSG · PACS
1. Valuation Multiples PACS
Forward P/E 20.1x 15.3x
Trailing P/E 26.3x 26.2x
PEG Ratio 1.40x 1.22x
EV / Revenue 2.2x 1.8x
2. Growth & Scale ENSG
Revenue Growth (YoY) +14.5% +11.5%
Earnings Growth (YoY) +23.9% +15.6%
TTM Revenue (USD) $5.67B $5.71B
Market Cap $10.3B $6.8B
3. Profitability & Quality ENSG
Gross Margin 17.1% 17.8%
Operating Margin 8.8% 7.4%
Net Profit Margin 7.0% 4.9%
Return on Equity (ROE) 17.1% 26.5%
4. Balance Sheet & Cash Flow ENSG
Cash Generation (TTM) $210M $8.2M
Cash Flow Margin 3.7% 0.1%
Net Cash / Leverage $1.95B Net Debt (0.89x D/E) $3.29B Net Debt (2.81x D/E)
Dividend Yield 0.14% None (0.00%)
5. Options & Positioning ENSG
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 99.5% (62nd %ile) 46.1% (11th %ile)
Put/Call OI Skew N/A 0.52x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat PACS
OpEx & R&D Intensity 8.3% of Rev ($471M) 10.4% of Rev ($593M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ENSG (6) vs PACS (3)
Institutional Metric ENSG PACS Criterion Row Edge
Market Capitalization
Scale
$10.3B $6.8B Larger Scale ENSG
Trailing P/E Ratio
Valuation
26.3x 26.2x Lower Multiple Tie
Forward P/E Ratio
Valuation
20.1x 15.3x Lower Multiple PACS
Revenue Growth (YoY)
Growth
+14.5% +11.5% Higher Growth ENSG
Operating Margin (TTM)
Profitability
8.8% 7.4% Higher Margin ENSG
Net Profit Margin
Profitability
7.0% 4.9% Higher Margin ENSG
Return on Equity (ROE)
Capital Efficiency
17.1% 26.5% Higher ROE PACS
52-Week Range Position
Momentum
46% ($142–$218) 79% ($14–$52) Stronger Trend PACS
Beta / 30D Volatility
Risk Regime
0.12β · 42% Vol 0.78β · 51% Vol Lower Realized Risk ENSG
Unified Institutional Score
Composite Signal
48.3 / 100 (HOLD) 46.8 / 100 (HOLD) Higher Composite ENSG
Trailing 12M Revenue (USD)
Operating Scale
$5.67B $5.71B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.1% 17.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.40x PEG · 2.2x EV/Rev 1.22x PEG · 1.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$210M ($1.95B Net Debt (0.89x D/E)) $8.2M ($3.29B Net Debt (2.81x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ENSG +6.92 pp
ENSG: -1.14% · PACS: -8.06%
3M Horizon PACS +0.39 pp
ENSG: -1.7% · PACS: -1.31%
6M Horizon PACS +13.13 pp
ENSG: +2.55% · PACS: +15.68%
1Y Horizon PACS +160.82 pp
ENSG: -1.34% · PACS: +159.48%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ENSG Revenue PACS Revenue ENSG Op. Margin PACS Op. Margin Margin Leader
FY2018 $1.75B N/A 4.8% N/A ENSG
FY2019 $2.04B N/A 6.3% N/A ENSG
FY2020 $2.39B N/A 9.3% N/A ENSG
FY2021 $2.63B N/A 9.9% N/A ENSG
FY2022 $3.03B $2.40B 9.8% 9.6% ENSG
FY2023 $3.71B $3.11B 6.9% 6.7% ENSG
FY2024 $4.24B $4.09B 8.5% 3.0% ENSG
FY2025 $5.03B $5.29B 8.5% 5.9% ENSG

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ENSG CONSOLIDATION
73d in phase · OBV NEUTRAL
Current IV 99.5%
IV Percentile 62nd %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ENSG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PACS CONSOLIDATION
83d in phase · OBV NEUTRAL
Current IV 46.1%
IV Percentile 11th %ile
Put/Call OI Skew 0.52x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact PACS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $49.00 · IV 47.5%

PACS Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($4,900)

Compare $4,900 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 47.5% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $50 / $55 Bull Call Spread

Buy 1x $50C · Sell 1x $55C · 32d

Net Entry $103 Debit
T+5d @ +5% Move +$65 (+63%)
Max Risk / Buffer $103 Capped
5d Edge & Liquidity 1.1x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $45 / $40 Bull Put Spread

Sell 1x $45P · Buy 1x $40P · 32d

Net Entry $104 Credit
Max Credit / Yield +$104 (+26.3% RoM)
Max Risk / Buffer -10.3% Cushion ($396 Mgn)
5d Edge & Liquidity 73% PoP · Liq C
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $45P / $50-$55C Seagull

Sell 1x $45P · Buy 1x $50/$55C · 32d

Net Entry $47 Credit
T+5d @ +5% Move +$146 (+21.3% RoM)
Max Risk / Buffer -8.2% Put Cushion ($683 Mgn)
5d Edge & Liquidity 1.1x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ENSG Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $10.3B market capitalization and 8.8% operating margin.
OpEx & R&D Reinvestment 8.3% of Rev ($471M)
90D Engineering Disclosures 0 Published
PACS Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $6.8B market capitalization and 7.4% operating margin.
OpEx & R&D Reinvestment 10.4% of Rev ($593M)
90D Engineering Disclosures 0 Published

Investor FAQ ENSG vs PACS Key Questions & Quantitative Answers

As of Nov 20, 2026, The Ensign Group, Inc. (ENSG) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ENSG carries a Unified Composite Score of 48.3/100 (HOLD) at $176.32 (20.1x Forward P/E, 8.8% operating margin), whereas PACS carries 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin). Technically, ENSG sits in a Neutral phase (RSI 43.5, CONSOLIDATION options structure) and PACS sits in a Neutral phase (RSI 39.2, CONSOLIDATION options structure).

ENSG leads the Growth & Scale pillar: ENSG posts +14.5% YoY revenue growth and +23.9% YoY earnings growth on $5.67B TTM revenue (17.1% gross margin, 8.8% operating margin), compared with PACS at +11.5% YoY revenue growth and +15.6% YoY earnings growth on $5.71B TTM revenue (17.8% gross margin, 7.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ENSG cumulative revenue shifted +187.4% while PACS shifted +120.4%. In operating R&D and SG&A reinvestment, ENSG deploys 8.3% of Rev ($471M) (0 90-day corporate R&D disclosures) versus 10.4% of Rev ($593M) (0 disclosures) for PACS.

PACS screens cheaper on headline valuation multiples. ENSG trades at 20.1x Forward P/E, 26.3x Trailing P/E, 1.40x PEG, and 2.2x EV/Revenue (3.7% FCF margin), whereas PACS trades at 15.3x Forward P/E, 26.2x Trailing P/E, 1.22x PEG, and 1.8x EV/Revenue (0.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ENSG (17.1% ROE) versus PACS (26.5% ROE) capital efficiency.

In options market volatility and institutional positioning, ENSG carries 99.5% implied volatility (62nd %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.12β · 42% Vol realized risk). By comparison, PACS carries 46.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.52x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.78β · 51% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.